DC Funds, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001869028

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 3 positions · Total reported value $1.25B · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 0 new · 0 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, DC Funds, LP disclosed 3 equity positions with a combined reported value of $1.25B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were TCRX ($617.46M), BRNS ($423.86M), HOWL ($212.02M). By sector, the heaviest allocations are Health Care 66.2%, Other 33.8%. Versus the prior quarter, allocation shifted toward Other (+9.2pp) and away from Health Care (-9.2pp).

Versus the prior quarter, DC Funds, LP opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 33.3% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest DC Funds, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

DC Funds, LP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 3 positions worth $1.25B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 3 positions · $1.25B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: TCRX (TScan Therapeutics Inc) at 49.3%
  • Average position size: $417.78M

Sector Tilt

  • Health Care 66.2%
  • (classified holdings cover 66% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund maintained its positions in the second quarter of 2026, indicating a conservative approach with a preference for stability and holding onto existing investments rather than making significant changes in response to market fluctuations. 2. Key Moves: The fund did not add any new positions and held all its existing holdings steady. This suggests a passive rebalancing strategy with no significant shifts in the portfolio composition. 3. Portfolio Structure: The portfolio appears to be passive in nature, with a sector bias towards Health Care, which is evident from the three holdings. The risk appetite is moderate, as the fund has not made any aggressive moves to increase exposure to higher-risk sectors or assets. 4. Per-Holding One-Liner: - TCRX (TScan Therapeutics Inc): A biotechnology company focusing on developing novel therapies for cancer. 'Unverified' - BRNS (VACCITECH PLC): A biotechnology company specializing in vaccine development. 'Unverified' - HOWL (WEREWOLF THERAPEUTICS INC): A biotechnology company working on therapies for rare and orphan diseases. 'Unverified' 5. One-Sentence Style Summary: The fund maintained a conservative, passive approach with a focus on Health Care, holding steady its existing positions without significant additions or deletions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 66.2%
Other 33.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 630.00K $617.46M 49.27%
49.27%
Hold
2 642.20K $423.86M 33.82%
33.82%
Hold
3 589.10K $212.02M 16.92%
16.92%
Hold

FAQ

What did DC Funds, LP buy in 2026-Q2?

In its 2026-Q2 13F filing, DC Funds, LP reported 3 equity positions worth $1.25B in aggregate; its largest disclosed positions were TCRX ($617.46M), BRNS ($423.86M), HOWL ($212.02M).

How large is DC Funds, LP's portfolio?

DC Funds, LP reported $1.25B of long equity holdings across 3 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is DC Funds, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/dc-funds/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →